Year |
Citation |
Score |
2016 |
Rawson JM, Roth ME, Xie J, Daly MB, Clouser CL, Landman SR, Reilly CS, Bonnac L, Kim B, Patterson SE, Mansky LM. Synergistic reduction of HIV-1 infectivity by 5-azacytidine and inhibitors of ribonucleotide reductase. Bioorganic & Medicinal Chemistry. PMID 27117260 DOI: 10.1016/J.Bmc.2016.03.052 |
0.646 |
|
2016 |
Daly MB, Roth ME, Bonnac L, Maldonado JO, Xie J, Clouser CL, Patterson SE, Kim B, Mansky LM. Dual anti-HIV mechanism of clofarabine. Retrovirology. 13: 20. PMID 27009333 DOI: 10.1186/S12977-016-0254-0 |
0.592 |
|
2016 |
Rawson JM, Daly MB, Xie J, Clouser CL, Landman SR, Reilly CS, Bonnac L, Kim B, Patterson SE, Mansky LM. 5-azacytidine enhances the mutagenesis of HIV-1 by reduction to 5-aza-2'-deoxycytidine. Antimicrobial Agents and Chemotherapy. PMID 26833151 DOI: 10.1128/Aac.03084-15 |
0.536 |
|
2016 |
Rawson JM, Clouser CL, Mansky LM. Rapid Determination of HIV-1 Mutant Frequencies and Mutation Spectra Using an mCherry/EGFP Dual-Reporter Viral Vector. Methods in Molecular Biology (Clifton, N.J.). 1354: 71-88. PMID 26714706 DOI: 10.1007/978-1-4939-3046-3_6 |
0.452 |
|
2014 |
Clouser CL, Bonnac L, Mansky LM, Patterson SE. Characterization of permeability, stability and anti-HIV-1 activity of decitabine and gemcitabine divalerate prodrugs. Antiviral Chemistry & Chemotherapy. 23: 223-30. PMID 23994876 DOI: 10.3851/Imp2682 |
0.649 |
|
2012 |
Clouser CL, Chauhan J, Bess MA, van Oploo JL, Zhou D, Dimick-Gray S, Mansky LM, Patterson SE. Anti-HIV-1 activity of resveratrol derivatives and synergistic inhibition of HIV-1 by the combination of resveratrol and decitabine. Bioorganic & Medicinal Chemistry Letters. 22: 6642-6. PMID 23010273 DOI: 10.1016/J.Bmcl.2012.08.108 |
0.651 |
|
2012 |
Clouser CL, Holtz CM, Mullett M, Crankshaw DL, Briggs JE, O'Sullivan MG, Patterson SE, Mansky LM. Activity of a novel combined antiretroviral therapy of gemcitabine and decitabine in a mouse model for HIV-1. Antimicrobial Agents and Chemotherapy. 56: 1942-8. PMID 22271861 DOI: 10.1128/Aac.06161-11 |
0.65 |
|
2012 |
Greggs WM, Clouser CL, Patterson SE, Mansky LM. Discovery of drugs that possess activity against feline leukemia virus. The Journal of General Virology. 93: 900-5. PMID 22258856 DOI: 10.1099/Vir.0.039909-0 |
0.596 |
|
2011 |
Greggs WM, Clouser CL, Patterson SE, Mansky LM. Broadening the use of antiretroviral therapy: the case for feline leukemia virus. Therapeutics and Clinical Risk Management. 7: 115-22. PMID 21479142 DOI: 10.2147/Tcrm.S17731 |
0.543 |
|
2011 |
Clouser CL, Holtz CM, Mullett M, Crankshaw DL, Briggs JE, Chauhan J, VanHoutan IM, Patterson SE, Mansky LM. Analysis of the ex vivo and in vivo antiretroviral activity of gemcitabine. Plos One. 6: e15840. PMID 21264291 DOI: 10.1371/Journal.Pone.0015840 |
0.488 |
|
2011 |
Ni Z, Knorr DA, Clouser CL, Hexum MK, Southern P, Mansky LM, Park IH, Kaufman DS. Human pluripotent stem cells produce natural killer cells that mediate anti-HIV-1 activity by utilizing diverse cellular mechanisms. Journal of Virology. 85: 43-50. PMID 20962093 DOI: 10.1128/Jvi.01774-10 |
0.592 |
|
2010 |
Clouser CL, Patterson SE, Mansky LM. Exploiting drug repositioning for discovery of a novel HIV combination therapy. Journal of Virology. 84: 9301-9. PMID 20610712 DOI: 10.1128/Jvi.01006-10 |
0.642 |
|
2009 |
Dapp MJ, Clouser CL, Patterson S, Mansky LM. 5-Azacytidine can induce lethal mutagenesis in human immunodeficiency virus type 1. Journal of Virology. 83: 11950-8. PMID 19726509 DOI: 10.1128/Jvi.01406-09 |
0.577 |
|
2009 |
Ni Z, Knorr DA, Clouser CL, Southern P, Mansky LM, Park I, Kaufman DS. Natural Killer Cells Derived From Human Pluripotent Stem Cells Provide a Novel Method to Treat HIV-1 Infection. Blood. 114: 280-280. DOI: 10.1182/Blood.V114.22.280.280 |
0.54 |
|
Show low-probability matches. |